For years, the treatment for injured or damaged organs has been mostly linear. It begins with drugs designed to combat symptoms and slow further loss of function. Some organs respond better than others, but in many cases deterioration is followed eventually by more invasive treatments—dialysis for renal failure, for example—or even organ transplant. These procedures can be costly and often carry with them the unnecessary risk of complication, such as rejection of the transplant or serious infection.

The SVF-2 will soon make cellular therapy a safe, effective alternative. This procedure uses the patient’s own cells to create a healing environment within their body. The goal is to enable the body’s healing intelligence to repair damage and prevent further deterioration. Although the device and therapy are still undergoing a clinical trial, they show promise for a variety of organ therapies.